Showing results (1601-1610 of 3,940) with videos related to

Sort By:
Pageof 394
European Journal of Human Genetics : EJHG|August 4, 2005
Mutation spectrum leading to an attenuated phenotype in dystrophinopathiesSylvie Tuffery-Giraud, Céline Saquet, Delphine Thorel, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|November 14, 2003
[Movement disorders in childhood: classification and genetic update]A Roubertie, F Rivier, S Tuffery-Giraud, et al.
Radiation Oncology (London, England)|April 5, 2018
Dosimetrical and radiobiological approach to manage the dosimetric shift in the transition of dose calculation algorithm in radiation oncology: how to improve high quality treatment and avoid unexpected outcomes?Abdulhamid Chaikh, Jarkko Ojala, Catherine Khamphan, et al.
Ecology and Evolution|May 22, 2019
Sympatry and interference of divergent Microbotryum pathogen speciesMichael E Hood, Janis Antonovics, Monroe Wolf, et al.
Clinical Oral Investigations|May 20, 2019
An international survey on the use of calcium silicate-based sealers in non-surgical endodontic treatmentM Guivarc'h, C Jeanneau, T Giraud, et al.
Drugs & Aging|January 21, 2021
Persistence of Effect of Medication Review on Potentially Inappropriate Prescriptions in Older Patients Following Hospital DischargeCamille Debacq, Julie Bourgueil, Amal Aidoud, et al.
Journal of Virological Methods|May 18, 1999
Generation of monoclonal antibodies to native human immunodeficiency virus type 1 envelope glycoprotein by immunization of mice with naked RNAA Giraud, Y Ataman-Onal, N Battail, et al.
Gastroenterologie Clinique Et Biologique|March 3, 1999
[Predictive risk factors for progression to cirrhosis in early stage alcoholic liver disease]V Giraud, S Naveau, A Balian, et al.
Journal of Internal Medicine|September 1, 1995
Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1C Larsson, A Calender, S Grimmond, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2004
Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy runVassilis E Kouloulias, Jean-Yves Giraud, Bernard J Davis, et al.
Pageof 394